WebMircera is authorized for the treatment of symptomatic anemia associated with chronic kidney disease (see SmPC for the full indication). It contains methoxy polyethylene glycol-epoetin beta as the active substance and it is given by subcutaneous or intravenous route. Further information about the evaluation of Mircera benefits can be found in ... WebMircera. methoxy peg-epoetin beta. This medication is used to treat anemia (low red blood cell count) in people with long-term serious kidney disease (chronic kidney disease). It works by signaling the bone marrow to make more red blood cells. Methoxy polyethylene glycol-epoetin beta helps to reverse anemia.

Mircera - assets.cwp.roche.com

Web1 dag geleden · It works by signaling the bone marrow to make more red blood cells. Methoxy polyethylene glycol -epoetin beta helps to reverse anemia. It also helps to reduce the need for blood transfusions.... Web5 aug. 2024 · NDC 59353-400-09 - MIRCERA® (methoxy polyethylene glycol-epoetin beta) 30 mcg / 0.3 mL - Sterile Solution - For intravenous or subcutaneous use only - … manitowoc ssi office

Continuous Erythropoiesis Receptor Activator - an overview ...

Web1 feb. 2008 · Methoxy polyethylene glycol-epoetin beta (PEG-EPO) is an erythropoiesis-stimulating agent (ESA) that can activate erythropoietin receptors on erythroid progenitor … Web31 okt. 2013 · To transform ESA doses to units of IV epoetin, we used conversion factors of 250:1 for darbepoetin alfa [21] and 208:1 (250/1.2) for methoxy polyethylene glycol-epoetin beta (pegylated epoetin-β ... WebThe starting dose of methoxy polyethylene glycol-epoetin beta is based on the calculated previous weekly dose of darbepoetin alfa or epoetin at the time of substitution as described in Table 1. The first injection should start at the next scheduled dose of the previously administered darbepoetin alfa or epoetin. Table 1: MIRCERA starting doses manitowoc steven avery case